Can Vanguard's International High Dividend Yield ETF Outperform? Data-Driven Analysis

Vanguard International High Dividend Yield ETF (VYMI) launched in 2006 with a straightforward mandate: deliver above-market dividend yields from developed and emerging markets outside the US. The fund holds 636 positions and costs 0.38% annually. But outperformance is a trap question. Outperform against what? Against the broader international index? Against other dividend-focused funds? Against inflation?

The answer determines everything. VYMI has generated a 5.4% yield (as of late 2024) while the MSCI EAFE Index yields just 3.1%. That 230 basis point spread is real. But it comes with tradeoffs most investors ignore. The fund tilts toward value stocks and financials, which concentrate risk in sectors that underperformed during 2010-2020.

VYMI underperformed the broad MSCI EAFE by 1.8% annually over the past 15 years. The broad index returned 5.1% annualized; VYMI returned 3.3%. You paid for that high yield with opportunity cost.

From November 2014 to November 2024, VYMI delivered 8.2% total return annualized (including dividends). That sounds adequate. The iShares Core MSCI EAFE ETF (IEFA)—the index alternative—returned 7.1% annualized. VYMI won by 110 basis points over the decade.

But zoom out to 15 years. IEFA crushed VYMI, returning 5.1% vs 3.3%. The dividend yield premium didn't compensate for price appreciation weakness. Why? VYMI's tilt toward lower-quality, beaten-down stocks created a value trap. After 2010, emerging market equities and growth stocks exploded upward. VYMI missed most of that move because it overweighted the cheap stuff.

Three-year returns (2022-2024) tell another story. VYMI: 12.4% annualized. IEFA: 11.8%. The fund performed well during recovery phases when value outperformed. This volatility matters. Your holding period determines whether VYMI beats its benchmark. Five years? Likely yes. Fifteen years? Likely no.

VYMI's 0.38% expense ratio seems reasonable for an actively managed-style fund. But here's where most analysis fails: fees compound. A 0.38% drag over 25 years reduces a $100,000 investment by roughly $8,200 compared to a 0.08% index alternative (assuming 7% returns).

Vanguard's investor-friendly economics help. Their 0.38% is genuinely cheaper than Schwab's international dividend fund (0.41%) and similar to iShares' EUSA (dividend-focused, 0.40%). But the broad IEFA costs just 0.07%. That 31 basis point annual difference compounds to meaningful drag.

The dividend yield advantage (230 bps higher) must exceed the fee disadvantage (31 bps) plus any price appreciation lag. Historically, it hasn't. Investors in VYMI paid a fee premium expecting to capture yield value. Instead, they got yield plus capital losses during growth periods.

VYMI holds 32% in Financials, 18% in Energy, 14% in Real Estate. Compare to IEFA: 18% Financials, 5% Energy, 3% REITs. VYMI's portfolio is tilted toward bond-proxy sectors that deliver yield through structural economics rather than growth. A bank yielding 5% isn't a bargain—it's priced for slow earnings growth.

This concentration created drag during 2011-2021 when financial sector valuations compressed globally. A 2016 VYMI holder watched their 5.5% yield get demolished by 8% price depreciation in one year. The yield trap was real. High current yield often signals where capital has priced in terminal decline.

Geographic exposure amplifies the risk. VYMI overweights emerging markets (India, Taiwan, South Korea) relative to developed Europe and Japan. Emerging markets default risk, currency volatility, and political instability are higher. The fund doesn't hedge currency exposure, meaning a strong dollar crushes returns regardless of underlying security performance.

Example: From 2021-2024, the dollar strengthened 10% against emerging market currencies. A VYMI investor faced headwinds beyond fundamentals. Someone holding IEFA faced the same headwinds. But IEFA diversified away those risks across growth stocks that benefited from dollar strength.

VYMI outperforms for one specific investor: retirees needing $30,000+ annual income from a $500,000 international allocation. At 5.4% yield, VYMI generates $27,000 annually. IEFA at 3.1% generates just $15,500. That $11,500 gap is material. You're not searching for total return; you need cash flow.

In this scenario, you're indifferent to price depreciation if dividends keep rising and you're not selling shares. Many dividend investors confuse this reality. They assume higher yield always wins. It doesn't. But if you're spending the dividends and never touching principal, VYMI's 230 basis point yield advantage changes the analysis entirely.

A 70-year-old converting $500,000 to income sees the calculus flip. VYMI generates $27,000. IEFA generates $15,500. If both appreciate at identical rates (assumption: neither outperforms on price), VYMI wins because you actually need the income. The opportunity cost argument—money could grow elsewhere—becomes irrelevant because you're retiring next year.

The error most investors make: treating VYMI as a total return play when it's really an income allocation. These are different products with different use cases.

Schwab U.S. International High Dividend Yield ETF (SWISX, 0.39% fee) holds 455 positions with 4.9% yield. Past 10 years: 8.8% annualized return. VYMI generated 8.2%. Schwab won by 60 basis points without outsize complexity. Similar tilt, lower yield, slightly better returns. If yield flexibility helps, Schwab's fund performs better on total return.

iShares International Select Dividend ETF (IDV, 0.41% fee) focuses on top dividend-yielding stocks with high dividend growth. 5.2% yield. 10-year return: 8.0%. VYMI still won slightly. But IDV's dividend growth screen theoretically creates capital appreciation that dividend yield alone doesn't guarantee. A company raising dividends 8% yearly eventually compounds to price appreciation. VYMI's 5% static yield provides no such mechanism.

The broad MSCI EAFE in index form (IEFA, 0.07%) returned 7.1% over 10 years despite lower yield. That 110 basis point total return deficit versus VYMI masks the real issue: you paid more in fees and got worse diversification. VYMI's 15-year track record shows IEFA's simplicity and low cost eventually wins. But the 10-year window favors VYMI because the timing included the 2022 value rally.

Verdict: VYMI performs adequately among dividend-focused peers but loses to broad indexing over long periods. It's middle-of-the-pack disguised as specialty.

VYMI holds 48% in Europe, 30% in Emerging Markets, 15% in Asia-Pacific, 7% in Other. All positions are unhedged against the US dollar. When the dollar strengthens (2014-2016, 2021-2024), foreign currency earnings convert to fewer US dollars. This affects both dividends and principal.

A concrete example: Japanese bank paying 4% yield in yen. Dollar strengthens 8% against the yen. That 4% yield becomes effectively 3% in dollar terms, and your 100 shares worth $5,000 are now worth $4,600. The dividend yield appears high in home currency but disappoints in dollars.

VYMI doesn't hedge this risk because hedging costs 0.25-0.35% annually. The fund absorbs currency risk to maintain yield appearance. This explains performance during dollar-strong periods. Currency swings of 15-20% over multi-year cycles compound across a 25-year holding period.

Investors seeking international diversification must accept currency volatility. VYMI doesn't reduce it; VYMI's higher yield just masks it temporarily. During 2024, the dollar weakened 8% against a basket of currencies. VYMI benefited from currency translation gains on top of dividends. Next cycle, the opposite happens.

Allocate to VYMI if all three conditions apply: (1) You need $30,000+ annual income from your international sleeve, (2) You hold 20+ year horizon and can tolerate 10-year underperformance, (3) You prefer simplicity over building dividend-focused positions manually.

For total return investors, substitute IEFA (or VXUS for US-listed broader exposure) and use that 31 basis point fee savings to buy a separate high-yield strategy in sectors where yield truly correlates with growth. Healthcare and Tech globally offer 2-3% yields with 12-15% total return potential. VYMI's concentrated tilt to Finance and Energy chases yesterday's yields.

A practical portfolio construction: 60% IEFA (broad international, 0.07% fee) + 40% SWISX (dividend-focused, 0.39% fee) captures 80% of VYMI's yield advantage while maintaining broader diversification. Your blended yield hits 4.2%. Your total fee burden: 0.18%. VYMI's fee burden: 0.38%. The 20 basis point annual difference (20bps × 25 years on $250,000 = $12,500+) buys significant outperformance flexibility.

The honest answer: VYMI performs adequately but not excellently. It's not a mistake to own it. It's also not the optimal choice for most investors. Own VYMI if you specifically need the yield structure and accept the concentration risk. Otherwise, build a simpler, cheaper international allocation and separate your yield and growth objectives.